Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice
Journal of Clinical Investigation · 15.07.2024 · 134 (14)
DOI: 10.1172/jci178250 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, online erschienen am 15.07.2024. Verfasst von Naima S Dahir und 10 weiteren Autor:innen. Beteiligte Einrichtung: Life Sciences Institute. Hauptthemen laut MEDLINE: Liraglutide, Receptor, Melanocortin, Type 3, Receptor, Melanocortin, Type 4. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
The melanocortin-3 receptor (MC3R) regulates GABA release from agouti-related protein (AgRP) nerve terminals and thus tonically suppresses multiple circuits involved in feeding behavior and energy homeostasis. Here, we examined the role of the MC3R and the melanocortin system in regulating the response to various anorexigenic agents. The genetic deletion or pharmacological inhibition of the MC3R, or subthreshold doses of an MC4R agonist, improved the dose responsiveness to glucagon-like peptide 1 (GLP1) agonists, as assayed by inhibition of food intake and weight loss. An enhanced anorectic response to the acute satiety factors peptide YY (PYY3-36) and cholecystokinin (CCK) and the long-term adipostatic factor leptin demonstrated that increased sensitivity to anorectic agents was a generalized result of MC3R antagonism. We observed enhanced neuronal activation in multiple hypothalamic nuclei using Fos IHC following low-dose liraglutide in MC3R-KO mice ( Mc3r –/– ), supporting the hypothesis that the MC3R is a negative regulator of circuits that control multiple aspects of feeding behavior. The enhanced anorectic response in Mc3r –/– mice after administration of GLP1 analogs was also independent of the incretin effects and malaise induced by GLP1 receptor (GLP1R) analogs, suggesting that MC3R antagonists or MC4R agonists may have value in enhancing the dose-response range of obesity therapeutics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Life Sciences Institute.
- Department of Molecular and Integrative Physiology, and.
- Department of Molecular, Cellular and Developmental Biology, University of Michigan, Ann Arbor, Michigan, USA.
- Department of Molecular and Integrative Physiology, University of Illinois, Urbana-Champaign, Illinois, USA.
- Courage Therapeutics, Newton, Massachusetts, USA.
- Department of Chemistry, School of Literature, Science, and the Arts, University of Michigan, Ann Arbor, Michigan, USA.
Förderung
- NIDDK NIH HHS
Zitieren
APA
Dahir, N. S., Gui, Y., Wu, Y., Sweeney, P. R., Rouault, A. A., Williams, S. Y., Gimenez, L. E., Sawyer, T. K., Joy, S. T., Mapp, A. K., & Cone, R. D. (2024). Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice. Journal of Clinical Investigation, 134(14). https://doi.org/10.1172/jci178250
Vancouver
Dahir NS, Gui Y, Wu Y, Sweeney PR, Rouault AA, Williams SY, et al. Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice. Journal of Clinical Investigation. 2024;134(14). doi:10.1172/jci178250
BibTeX
@article{Dahir2024,
author = {Dahir, Naima S and Gui, Yijun and Wu, Yanan and Sweeney, Patrick R and Rouault, Alix Aj and Williams, Savannah Y and Gimenez, Luis E and Sawyer, Tomi K and Joy, Stephen T and Mapp, Anna K and Cone, Roger D},
title = {Subthreshold activation of the melanocortin system causes generalized sensitization to anorectic agents in mice},
journal = {Journal of Clinical Investigation},
year = {2024},
volume = {134},
number = {14},
doi = {10.1172/jci178250}
}
EUVIMED